How much does a box of Valganciclovir cost? Latest prices in 2025
Valganciclovir is an oral antiviral drug used against cytomegalovirus (CMV) infection. It is often used for the prevention and treatment of CMV in people with low immune function. Its mechanism is based on the inhibition of viral DNA synthesis after conversion of prodrugs, and its preventive effect on postoperative CMV infection in transplant patients is clear. In addition, it is also used to control the progression of CMV retinitis in HIV-infected patients. In recent years, this drug has become an important drug choice in the field of anti-CMV. Its oral administration method has greatly improved patient compliance and replaced some older-generation drugs that require intravenous injection.

Regarding price and procurement channels, the original drug of valganciclovir has been officially launched in mainland China, but it has not yet been included in the national medical insurance catalog, resulting in a relatively high price. Taking the specification of 0.45g and 60 tablets as an example, the price of each box of domestic original medicine is more than 10,000 yuan. The specific cost is also limited by the city, hospital pharmacy supply system and policy adjustments.
In overseas channels, the price of the original version imported from Switzerland is relatively stable, while the Indian and Turkish versions have certain differences due to exchange rate fluctuations and the price strategies of international pharmaceutical agents. The usual price range is between RMB 4,000 and RMB 15,000. Some patients choose to purchase from regular channels in Hong Kong, Macao or overseas pharmacies to obtain a certain price relief.
In addition, the generic version of valganciclovir produced by Laos Lucius Pharmaceutical Factory has also attracted attention in recent years. The specification of this version of the drug is450 mg 60 tablets, with obvious price advantages. The latest batch of market quotations is around RMB 1,000 to 1,500 yuan. Although it is a generic drug, its active ingredients are consistent with the original drug and fall within the internationally accepted drug equivalence category, and are widely used in clinical alternative treatments in many countries. When choosing a drug version, patients need to weigh price, efficacy, safety and compliance with access.
Reference materials:https://go.drugbank.com/drugs/DB01610
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)